Efficacy of adjuvant trastuzumab (T) compared with no T for patients (pts) with HER2-positive breast cancer and tumors ≤2cm: A meta-analysis of the randomized trastuzumab trials.

被引:0
|
作者
O'Sullivan, Ciara Catherine Maria
Bradbury, Ian
De Azambuja, Evandro
Perez, Edith A.
Rastogi, Priya
Spielmann, Marc
Joensuu, Heikki
Ballman, Karla V.
Costantino, Joseph P.
Delaloge, Suzette
Zardavas, Dimitrios
Piccart-Gebhart, Martine J.
Zujewski, JoAnne
Holmes, Eileen McCormick
Gelber, Richard D.
机构
[1] NCI, Bethesda, MD 20892 USA
[2] Fronfier Sci, Kincraig, England
[3] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium
[4] Mayo Clin, Jacksonville, FL 32224 USA
[5] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[6] Inst Gustave Roussy, Villejuif, France
[7] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland
[8] Mayo Clin, Rochester, MN USA
[9] Univ Pittsburgh, Grad Sch Publ Hlth, Natl Surg Adjuvant Breast & Bowel Project, Biostat Ctr, Pittsburgh, PA USA
[10] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA USA
[11] Inst Cancerol Gustave Roussy, Villejuif, France
[12] Breast Int Grp, Inst Jules Bordet, Brussels, Belgium
[13] Frontier Sci Scotland, Kingussie, Inverness, Scotland
[14] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
508
引用
收藏
页数:1
相关论文
共 50 条
  • [1] ADJUVANT TRASTUZUMAB THERAPY IN HER2-POSITIVE BREAST CANCER PATIENTS: A META-ANALYSIS OF PUBLISHED RANDOMIZED TRIALS
    Xia, Y.
    Bian, B.
    Costea, E.
    Kelton, C. M.
    Guo, J. J.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A128 - A128
  • [2] Adjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer Patients: A Meta-Analysis of Published Randomized Trials
    Xia, Ying
    Bian, Boyang
    Costea, Elizabeth
    Guo, Jeff
    Kelton, Christina
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 131 - 132
  • [3] Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials
    Yin, Wenjin
    Jiang, Yiwei
    Shen, Zhenzhou
    Shao, Zhimin
    Lu, Jinsong
    [J]. PLOS ONE, 2011, 6 (06):
  • [4] Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials
    O'Sullivan, Ciara C.
    Bradbury, Ian
    Campbell, Christine
    Spielmann, Marc
    Perez, Edith A.
    Joensuu, Heikki
    Costantino, Joseph P.
    Delaloge, Suzette
    Rastogi, Priya
    Zardavas, Dimitrios
    Ballman, Karla V.
    Holmes, Eileen
    de Azambuja, Evandro
    Piccart-Gebhart, Martine
    Zujewski, Jo Anne
    Gelber, Richard D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) : 2600 - U37
  • [5] Pertuzumab combined with trastuzumab compared to trastuzumab in the treatment of HER2-positive breast cancer: A systematic review and meta-analysis of randomized controlled trials
    Liu, Xiaoyun
    Fang, Yingying
    Li, Yinjuan
    Li, Yan
    Qi, Lu
    Wang, Xinghe
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
    Slamon, Dennis
    Eiermann, Wolfgang
    Robert, Nicholas
    Pienkowski, Tadeusz
    Martin, Miguel
    Press, Michael
    Mackey, John
    Glaspy, John
    Chan, Arlene
    Pawlicki, Marek
    Tamas Pinter
    Valero, Vicente
    Liu, Mei-Ching
    Sauter, Guido
    von Minckwitz, Gunter
    Visco, Frances
    Bee, Valerie
    Buyse, Marc
    Bendahmane, Belguendouz
    Tabah-Fisch, Isabelle
    Lindsay, Mary-Ann
    Riva, Alessandro
    Crown, John
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1273 - 1283
  • [7] Adjuvant trastuzumab for HER2-positive breast cancer
    Spicer, J
    Harries, M
    Ellis, P
    [J]. LANCET, 2005, 366 (9486): : 634 - 634
  • [8] Efficacy of vinorelbine plus trastuzumab (VT) in patients (pts) with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab (T).
    Freixinos, V.
    Sanchez-Olle, G.
    De Mattos-Arruda, L.
    Di Cosimo, S.
    Saura, C.
    Gomez, P.
    Perez-Garcia, J. M.
    Cortes, J.
    Baselga, J.
    Bellet, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials
    Gustavo A Viani
    Sergio L Afonso
    Eduardo J Stefano
    Ligia I De Fendi
    Francisco V Soares
    [J]. BMC Cancer, 7
  • [10] Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials
    Viani, Gustavo A.
    Afonso, Sergio L.
    Stefano, Eduardo J.
    De Fendi, Ligia I.
    Soares, Francisco V.
    [J]. BMC CANCER, 2007, 7 (1)